T Cell Receptor Chain Centricity: The Phenomenon and Potential Applications in Cancer Immunotherapy

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Oct 28

PMID 37894892

Authors

Anastasiia A Kalinina

Ludmila M Khromykh

Dmitry B Kazansky

Affiliations

Soon will be listed here.

Abstract

T cells are crucial players in adaptive anti-cancer immunity. The gene modification of T cells with tumor antigen-specific T cell receptors (TCRs) was a milestone in personalized cancer immunotherapy. TCR is a heterodimer (either α/β or γ/δ) able to recognize a peptide antigen in a complex with self-MHC molecules. Although traditional concepts assume that an α- and β-chain contribute equally to antigen recognition, mounting data reveal that certain receptors possess chain centricity, i.e., one hemi-chain TCR dominates antigen recognition and dictates its specificity. Chain-centric TCRs are currently poorly understood in terms of their origin and the functional T cell subsets that express them. In addition, the ratio of α- and β-chain-centric TCRs, as well as the exact proportion of chain-centric TCRs in the native repertoire, is generally still unknown today. In this review, we provide a retrospective analysis of studies that evidence chain-centric TCRs, propose patterns of their generation, and discuss the potential applications of such receptors in T cell gene modification for adoptive cancer immunotherapy.

Citing Articles

TCR repertoire dynamics and their responses underscores dengue severity.

Khare K, Yadav S, Tarai B, Budhiraja S, Pandey R iScience. 2024; 27(10):110983.

PMID: 39403197 PMC: 11472631. DOI: 10.1016/j.isci.2024.110983.

References

Buch T, Rieux-Laucat F, Forster I, Rajewsky K . Failure of HY-specific thymocytes to escape negative selection by receptor editing. Immunity. 2002; 16(5):707-18. DOI: 10.1016/s1074-7613(02)00312-6. View

Stronen E, Toebes M, Kelderman S, van Buuren M, Yang W, van Rooij N . Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. Science. 2016; 352(6291):1337-41. DOI: 10.1126/science.aaf2288. View

Zhao Y, Nguyen P, Vogel P, Li B, Jones L, Geiger T . Autoimmune susceptibility imposed by public TCRβ chains. Sci Rep. 2016; 6:37543. PMC: 5116635. DOI: 10.1038/srep37543. View

Garcia-Leon M, Fuentes P, de la Pompa J, Toribio M . Dynamic regulation of NOTCH1 activation and Notch ligand expression in human thymus development. Development. 2018; 145(16). DOI: 10.1242/dev.165597. View

Silaeva Y, Grinenko T, Vagida M, Kalinina A, Khromykh L, Kazansky D . Immune selection of tumor cells in TCR β-chain transgenic mice. J Immunotoxicol. 2013; 11(4):393-9. DOI: 10.3109/1547691X.2013.861548. View

Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A . Expression of two T cell receptor alpha chains: dual receptor T cells. Science. 1993; 262(5132):422-4. DOI: 10.1126/science.8211163. View

MERKENSCHLAGER M, Benoist C, Mathis D . Evidence for a single-niche model of positive selection. Proc Natl Acad Sci U S A. 1994; 91(24):11694-8. PMC: 45298. DOI: 10.1073/pnas.91.24.11694. View

Fink P, Bevan M . Positive selection of thymocytes. Adv Immunol. 1995; 59:99-133. DOI: 10.1016/s0065-2776(08)60630-6. View

Davis M, Bjorkman P . T-cell antigen receptor genes and T-cell recognition. Nature. 1988; 334(6181):395-402. DOI: 10.1038/334395a0. View

10.

von Essen M, Bonefeld C, Siersma V, Rasmussen A, Lauritsen J, Nielsen B . Constitutive and ligand-induced TCR degradation. J Immunol. 2004; 173(1):384-93. DOI: 10.4049/jimmunol.173.1.384. View

11.

Zamkova M, Kalinina A, Silaeva Y, Persiyantseva N, Bruter A, Deikin A . Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in experiments. Oncotarget. 2019; 10(47):4808-4821. PMC: 6690675. DOI: 10.18632/oncotarget.27093. View

12.

Lichterfeld M, Yu X, Mui S, Williams K, Trocha A, Brockman M . Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol. 2007; 81(8):4199-214. PMC: 1866095. DOI: 10.1128/JVI.01388-06. View

13.

Silaeva Y, Kalinina A, Vagida M, Khromykh L, Deikin A, Ermolkevich T . Decrease in pool of T lymphocytes with surface phenotypes of effector and central memory cells under influence of TCR transgenic β-chain expression. Biochemistry (Mosc). 2013; 78(5):549-59. DOI: 10.1134/S0006297913050143. View

14.

Kalinina A, Bruter A, Persiyantseva N, Silaeva Y, Zamkova M, Khromykh L . Safety evaluation of the mouse TCRα - transduced T cell product in preclinical models in vivo and in vitro. Biomed Pharmacother. 2021; 145:112480. DOI: 10.1016/j.biopha.2021.112480. View

15.

Dietrich P, Le Gal F, Dutoit V, Pittet M, Trautman L, Zippelius A . Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol. 2003; 170(10):5103-9. DOI: 10.4049/jimmunol.170.10.5103. View

16.

Liu H, Rhodes M, Wiest D, Vignali D . On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity. 2000; 13(5):665-75. DOI: 10.1016/s1074-7613(00)00066-2. View

17.

Fink P, McMahan C . Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe. Immunol Today. 2000; 21(11):561-6. DOI: 10.1016/s0167-5699(00)01734-5. View

18.

McGargill M, Derbinski J, Hogquist K . Receptor editing in developing T cells. Nat Immunol. 2001; 1(4):336-41. DOI: 10.1038/79790. View

19.

McMahan C, Fink P . RAG reexpression and DNA recombination at T cell receptor loci in peripheral CD4+ T cells. Immunity. 1998; 9(5):637-47. DOI: 10.1016/s1074-7613(00)80661-5. View

20.

DIppolito E, Schober K, Nauerth M, Busch D . T cell engineering for adoptive T cell therapy: safety and receptor avidity. Cancer Immunol Immunother. 2019; 68(10):1701-1712. PMC: 11028346. DOI: 10.1007/s00262-019-02395-9. View